Average Co-Inventor Count = 6.26
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Biotechnology Ltd (11 from 93 patents)
2. Abbvie Inc. (2 from 822 patents)
3. Abbott Laboratories Corporation (1 from 4,179 patents)
4. Abbvie Deutschland Gmbh and Co Kg (1 from 167 patents)
14 patents:
1. 9512216 - Use of TNFα inhibitor
2. 9499615 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease
3. 9187559 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease
4. 9090689 - Use of TNFα inhibitor for treatment of psoriasis
5. 9085620 - Use of TNFα inhibitor for treatment of psoriatic arthritis
6. 9061005 - Multiple-variable dose regimen for treating idiopathic inflammatory bowel disease
7. 9051368 - Methods for treating psoriasis by administering an antibody which binds an epitope of the p40 subunit of IL-12 and/or IL-23
8. 8986693 - Use of TNFα inhibitor for treatment of psoriasis
9. 8961973 - Multiple-variable dose regimen for treating TNFα-related disorders
10. 8961974 - Multiple-variable dose regimen for treating TNFα-related disorders
11. 8906373 - Use of TNF-alpha inhibitor for treatment of psoriasis
12. 8889136 - Multiple-variable dose regimen for treating TNFα-related disorders
13. 8557239 - Methods for treating psoriasis using antibodies that bind to the P40 subunit of IL-12 and/or IL-23
14. 7776331 - Methods of treating plaque psoriasis